Targeting enzyme could alleviate muscle wasting for cancer patients

byUniversity of Texas Health Science Center at HoustonCredit: Pixabay/CC0 Public DomainTargeting a specific enzyme in the muscle could help cancer patients preserve muscle mass and potentially p

Updated on: December 19,2023 8

Targeting enzyme could alleviate muscle wasting for cancer patients

byUniversity of Texas Health Science Center at HoustonCredit: Pixabay/CC0 Public DomainTargeting a specific enzyme in the muscle could help cancer patients preserve muscle mass and potentially p

Updated on:December 19,2023 8

Lorazepam may Fuel Poor Pancreatic Cancer Outcome!

byHemalatha Manikandanon August 17, 2023Lorazepamis a drug, frequently used to relieve anxiety in cancer patients. Studies reveal that,Pancreatic cancerpatients who took

Updated on: December 19,2023 24

Lorazepam may Fuel Poor Pancreatic Cancer Outcome!

byHemalatha Manikandanon August 17, 2023Lorazepamis a drug, frequently used to relieve anxiety in cancer patients. Studies reveal that,Pancreatic cancerpatients who took

Updated on:December 19,2023 24

Advancing Against Melanoma With Microneedles Technology

byColleen Fleisson August 22, 2023A novel strategy that combines a painless, minimally invasivemicroneedleplatform with the ability to absorb biomarker-rich fluid from the skin

Updated on: December 19,2023 42

Advancing Against Melanoma With Microneedles Technology

byColleen Fleisson August 22, 2023A novel strategy that combines a painless, minimally invasivemicroneedleplatform with the ability to absorb biomarker-rich fluid from the skin

Updated on:December 19,2023 42

Immunotherapy improves survival for people with aggressive, asbestos-linked lung cancer

byCancer Research UK| News30 January 2021People with an aggressive form of lung cancer that’s come back after treatment, leaving them with limited options, could live longer when treated w

Updated on: December 19,2023 26

Immunotherapy improves survival for people with aggressive, asbestos-linked lung cancer

byCancer Research UK| News30 January 2021People with an aggressive form of lung cancer that’s come back after treatment, leaving them with limited options, could live longer when treated w

Updated on:December 19,2023 26

Immunotherapy Combo Boosts Survival in Metastatic Melanoma

byColleen Fleisson August 19, 2023For patients diagnosed with advancedmetastatic melanomathat does not respond to the commonly utilized PD-1 inhibitors, immunotherapy drugs ipi

Updated on: December 19,2023 16

Immunotherapy Combo Boosts Survival in Metastatic Melanoma

byColleen Fleisson August 19, 2023For patients diagnosed with advancedmetastatic melanomathat does not respond to the commonly utilized PD-1 inhibitors, immunotherapy drugs ipi

Updated on:December 19,2023 16

Targeted drug tagrisso could be advance against lung cancer

Updated on: December 19,2023 8

Targeted drug tagrisso could be advance against lung cancer

Updated on:December 19,2023 8

Promising Biomarkers for Early Detection of Prostate Cancer Risk Identified

byColleen Fleisson August 18, 2023A cell metabolism process observed in males who have diabetes and metastatic prostate cancer holds the potential for future advancements in testing and tr

Updated on: December 19,2023 26

Promising Biomarkers for Early Detection of Prostate Cancer Risk Identified

byColleen Fleisson August 18, 2023A cell metabolism process observed in males who have diabetes and metastatic prostate cancer holds the potential for future advancements in testing and tr

Updated on:December 19,2023 26

Targeting cancer-supporting cells boosts immunotherapy in previously insensitive tumors

byInstitute of Cancer ResearchHuman breast cancer cells implanted in an experimental animal with two different tracers (red and blue) to investigate the interaction of tumour cells. Credit:&nbsp

Updated on: December 19,2023 12

Targeting cancer-supporting cells boosts immunotherapy in previously insensitive tumors

byInstitute of Cancer ResearchHuman breast cancer cells implanted in an experimental animal with two different tracers (red and blue) to investigate the interaction of tumour cells. Credit:&nbsp

Updated on:December 19,2023 12

Targeted therapy momelotinib provides significant symptom and anemia improvements in patients with myelofibrosis

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainPatients with myelofibrosis had clinically significant improvement in disease-related symptoms, including anem

Updated on: December 19,2023 10

Targeted therapy momelotinib provides significant symptom and anemia improvements in patients with myelofibrosis

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainPatients with myelofibrosis had clinically significant improvement in disease-related symptoms, including anem

Updated on:December 19,2023 10

Study opens door to targeted treatments for oesophageal cancer

byCancer Research UK| News5 September 2016Scientists have discovered thatoesophageal cancercan be classified into three different subtypes, paving the way for testing targeted

Updated on: December 19,2023 26

Study opens door to targeted treatments for oesophageal cancer

byCancer Research UK| News5 September 2016Scientists have discovered thatoesophageal cancercan be classified into three different subtypes, paving the way for testing targeted

Updated on:December 19,2023 26

Less chemotherapy better for older or frail patients with advanced stomach and oesophageal cancers

byCancer Research UK| News15 May 2019Less chemotherapy is as effective at controlling disease for elderly or frail patients with advanced cancer of the stomach or oesophagus (food pipe), a

Updated on: December 19,2023 19

Less chemotherapy better for older or frail patients with advanced stomach and oesophageal cancers

byCancer Research UK| News15 May 2019Less chemotherapy is as effective at controlling disease for elderly or frail patients with advanced cancer of the stomach or oesophagus (food pipe), a

Updated on:December 19,2023 19

Progression-free survival increased with zanubrutinib in leukemia

by Elana Gotkine HealthDay ReporterProgression-free survival is significantly longer with zanubrutinib than ibrutinib among patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or s

Updated on: December 19,2023 12

Progression-free survival increased with zanubrutinib in leukemia

by Elana Gotkine HealthDay ReporterProgression-free survival is significantly longer with zanubrutinib than ibrutinib among patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or s

Updated on:December 19,2023 12